Workflow
Unity Software: The Inflection Point No One's Talking About
Seeking Alpha· 2025-04-23 18:09
Michael Wiggins De Oliveira is an inflection investor. This means buying into cheap companies at the moment when their narrative is changing and the business is on a path toward becoming significantly more profitable over the next year.With a focus on tech and “the Great Energy Transition (including uranium)”, Michael runs a concentrated portfolio with approximately 15 to 20 stocks and an average holding period of 18 months. Through his 10+ years analyzing countless companies, Michael has accumulated outsta ...
Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?
The Motley Fool· 2025-04-23 18:01
Amid a bullish backdrop for the broader market, Tempus AI (TEM 17.72%) stock is posting big gains Wednesday. The company's share price was up 15.8% as of 1:45 p.m. ET. At the same point in time, the S&P 500 was up 2.1%, and the Nasdaq Composite had risen 2.8%.Investors are having a strong positive reaction to news that the Trump administration is apparently interested in getting a trade deal done with China and lowering tariffs in the not-too-distant future. In addition to buying momentum that's lifting val ...
AON to Report Q1 Earnings: What Do the Key Estimates Say?
ZACKS· 2025-04-23 18:00
Leading insurer Aon PLC (AON) is set to report its first-quarter 2025 results on April 25, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $6.04 per share on revenues of $4.86 billion. (See the Zacks Earnings Calendar to stay ahead of market-making news.)The first-quarter earnings estimate has been constant over the past week. The bottom-line projection indicates a year-over-year increase of 6.7%. Moreover, the Zacks Consensus Estimate f ...
The Hartford to Release Q1 Earnings: Key Estimates to Watch
ZACKS· 2025-04-23 18:00
The Hartford Insurance Group, Inc. (HIG) is scheduled to release first-quarter 2025 results on April 24, after market close. The Zacks Consensus Estimate for earnings is pegged at $2.13 per share, which indicates a decline of 9% from the prior-year quarter’s number.  (See the Zacks Earnings Calendar to stay ahead of market-making news.)The first-quarter earnings estimate has witnessed no upward estimate revisions against six downward movements over the past 30 days. Meanwhile, the Zacks Consensus Estimate f ...
Are Apple ETFs Ripe for a Rebound?
ZACKS· 2025-04-23 18:00
Apple (AAPL) shares have outperformed the S&P 500 over the past week, falling just 1% compared to the index’s 2.3% decline. And why not? The beaten-down iPhone maker, which is down 18% so far this year, has been receiving a string of good news lately.On April 12, 2025, President Donald Trump reportedly excluded smartphones, laptops, and various other tech devices and components from his newly imposed reciprocal tariffs. According to the White House, these exemptions were granted to give companies time to sh ...
Range Resources Q1 Earnings Beat on Higher Price Realizations
ZACKS· 2025-04-23 17:55
Financial Performance - Range Resources Corporation (RRC) reported first-quarter 2025 adjusted earnings of 96 cents per share, exceeding the Zacks Consensus Estimate of 90 cents and improving from 69 cents in the prior year [1] - Total quarterly revenues reached $854 million, surpassing the Zacks Consensus Estimate of $811 million and increasing from $721 million year-over-year [1] Operational Performance - Production averaged 2,200.3 million cubic feet equivalent per day (Mcfe/d), up from 2,141.5 Mcfe/d in the same quarter last year and exceeding the projection of 2,169.3 Mcfe/d [2] - Natural gas contributed approximately 69% to total production, with natural gas production increasing by 4% year-over-year, while oil production decreased by 30% and NGL output increased by 3% [2] Price Realization - Total price realization averaged $4 per Mcfe, a 37% increase year-over-year, although lower than the estimate of $4.08 per Mcfe [3] - Natural gas price rose by 76% year-over-year to $3.61 per Mcf, while NGL price increased by 6% and oil price fell by 5% [3] Costs & Expenses - Total costs and expenses increased by 9% year-over-year to $580.8 million, exceeding the expectation of $562.9 million [4] - Transportation, gathering, processing, and compression costs rose to $306.1 million from $290.9 million in the prior-year quarter [4] Capital Expenditure & Balance Sheet - Drilling and completion expenditure was $130 million, with an additional $16 million spent on acreage and $1 million on infrastructure and other investments [5] - At the end of the first quarter, total debt stood at $1,696.5 million, net of deferred financing costs [5] Outlook - Range Resources expects total production for 2025 to be 2.2 billion cubic feet equivalent per day, with over 30% attributed to liquids production [6] - The company has projected a capital budget of $650-$690 million for the year [6]
Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up
ZACKS· 2025-04-23 17:55
Core Insights - Thermo Fisher Scientific Inc. reported first-quarter 2025 adjusted earnings per share (EPS) of $5.15, exceeding the Zacks Consensus Estimate by 1% and reflecting a year-over-year increase of 0.8% [1] - The company's GAAP EPS was $3.98, marking a 15% increase year over year [1] - Following the earnings announcement, shares of Thermo Fisher rose 1.7% in pre-market trading [2] Revenue Performance - Total revenues for the quarter reached $10.36 billion, a 0.2% increase year over year, surpassing the Zacks Consensus Estimate by 1.1% [3] - Organic revenues increased by 1% year over year [3] Segment Analysis - Life Sciences Solutions segment (22.6% of total revenues) saw revenues increase by 2.4% year over year to $2.34 billion, exceeding estimates [4] - Analytical Instruments segment (16.6%) reported a 1.8% year-over-year increase in revenues to $1.72 billion, which fell short of estimates [5] - Specialty Diagnostics segment (11.1%) experienced a 3.5% year-over-year revenue increase to $1.15 billion, surpassing predictions [6] - Laboratory Products and Biopharma Services segment (54.4%) saw a decline of 1.4% year over year, with revenues at $5.64 billion, slightly below estimates [7] Margin Performance - Gross margin for the first quarter was 41.6%, contracting by 5 basis points year over year due to a 0.3% rise in the cost of revenues [8] - Selling, general and administrative expenses decreased by 0.6% to $1.72 billion, while research and development expenses increased by 3.3% to $342 million [8] - Adjusted operating margin was 21.7%, reflecting a contraction of 2 basis points [8] Financial Position - At the end of Q1 2025, cash and cash equivalents and short-term investments totaled $5.95 billion, up from $5.57 billion at the end of Q4 2024 [9] - Net cash from operating activities was $723 million, down from $1.25 billion a year ago [10] - The company has a consistent dividend-paying history, with a five-year annualized dividend growth of 15.10% [10] Strategic Developments - During the first quarter, Thermo Fisher launched several innovative products, including the Thermo Scientific Vulcan Automated Lab and Olink Reveal proteomics kits, contributing to commercial success [12] - The company announced an agreement to acquire Solventum's Purification & Filtration Business for $4.1 billion in cash [12] Overall Assessment - Thermo Fisher's first-quarter results exceeded expectations in terms of earnings and revenues, with growth in most segments except for Laboratory Products and Biopharma Services [11] - The contraction in margins was noted as a concern, and the company is expected to provide guidance for 2025 in an upcoming earnings call [11]
Pfizer Earnings Preview: Pharma May Plumb New Depths After Obesity Drug Debacle
Seeking Alpha· 2025-04-23 17:52
If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.Pfizer Inc. (NYSE: PFE ), the New York-based Pharma giant whose COVID vaccine Comirnaty earned the company >$85bn between 2021–2023, and whose COVID antiviral Paxlovid earn ...
TSCO Introduces Tractor Supply Rx to Facilitate Pet Pharmacy Offerings
ZACKS· 2025-04-23 17:50
Core Insights - Tractor Supply Company (TSCO) is leveraging its Life Out Here Strategy, 'ONETractor' Strategy, and Neighbor's Club membership program to drive growth through new launches and innovations [1][5] Product Launch and Features - The company has introduced Tractor Supply Rx, a low-cost pet and animal pharmacy, which allows customers to enroll in automatic delivery via the Autoship program and access expert pharmacy advice [2][3] - Customers can easily request medications and share their pet and veterinarian's details, with same-day shipping available for prescriptions [3][4] - The new launch includes additional services such as pet wash stations, grooming at Petsense, and veterinary care through a partnership with PetVet [4] Membership and Customer Engagement - The company aims to reach approximately 38 million Neighbor's Club members with its pharmacy solutions, integrating digital pharmacy services into its stores [5] - Neighbor's Club members can benefit from rewards and exclusive offers, enhancing customer loyalty and savings [3][4] Strategic Initiatives - TSCO is focused on its 'ONETractor' strategy, which connects in-store and online shopping experiences, supported by investments in curbside pickup, same-day and next-day delivery, and a revamped website and mobile app [6] - The company is expanding its store base and incorporating technology to drive traffic and revenue, with Project Fusion aimed at improving customer experience in existing stores [7] Financial Performance and Market Position - Despite the growth initiatives, TSCO's shares have declined by 11.6% over the past three months, compared to a 20.6% decline in the industry [8] - The company is facing challenges with rising selling, general and administrative (SG&A) costs, which are attributed to growth investments and the onboarding of a new distribution center [10]
ROSEN, THE FIRST FILING FIRM, Encourages Ibotta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – IBTA
GlobeNewswire News Room· 2025-04-23 17:50
Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Ibotta, Inc. securities related to its April 18, 2024 IPO, alleging that the Registration Statement contained false or misleading statements regarding the risks associated with Ibotta's contract with Kroger [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Ibotta failed to disclose that its contract with Kroger was at-will, meaning Kroger could terminate the contract without notice, which posed a significant risk to investors [5]. - Ibotta provided detailed terms of its contract with another large customer but did not mention the at-will nature of the Kroger contract, leading to investor damages when the true nature of the contract was revealed [5]. Group 2: Investor Participation - Investors who purchased Ibotta securities may be entitled to compensation through a contingency fee arrangement, meaning no out-of-pocket fees or costs are required [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].